noscript

News and Announcements

OncoSil Medical CEO Presentation & AGM October 2016

  • Published October 18, 2016 3:29PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

18th October 2016, ASX Announcement

Achievements Delivered FY16

September 2015 – Submission of CE Mark application for OncoSil™

October 2015 – OncoSil™ CE Mark application granted Fast Track review status

December 2015 – Investigational Device Exemption submitted to the FDA for OncoPac-1 clinical study

January 2016 – Chris Roberts appointed Independent Non-Executive Director

February 2016 – $10 million private placement to Regal Funds Management

March – April 2016 – Q-Submissions meeting with FDA
-Responses to CE Mark and FDA questions

May 2016 – OncoSil Medical completes hiring of senior management for the Leadership Team

June 2016 – IDE Amendment submitted to the FDA for OncoPac-1 clinical study

To view the full Presentation, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now